Chilton Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53
Closed -$6.25K 668
2026
Q1
$6.25K Buy
+53
New +$7.4K ﹤0.01% 521
2024
Q4
Sell
-143
Closed -$21.3K 658
2024
Q3
$21.3K Hold
143
﹤0.01% 425
2024
Q2
$18K Buy
+143
New +$22.4K ﹤0.01% 454

Other funds holding RGEN

Chilton Capital Management's RGEN Position: Q2 2026 in Review

Chilton Capital Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 53 shares — an estimated $6.25K sold.

Chilton Capital Management first reported a position in RGEN in Q2 2024 and held it in 3 quarters. The position peaked at $21.3K in Q3 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Chilton Capital Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Chilton Capital Management sold 53 Repligen shares in Q2 2026, an estimated $6.25K.
  • Chilton Capital Management first reported a position in Repligen in Q2 2024 and held it in 3 quarters.
  • Chilton Capital Management's Repligen position peaked at $21.3K in Q3 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.